Urology-Textbook.com

Up-to-date urology insights from Dirk Manski

 You are here: Urology Textbook > Pharmacology

Pharmacology of Drugs on Urology

Medical Treatment of Benign Prostatic Hyperplasia

Analgetics

Androgen Deprivation Therapy

Androgen deprivation therapy (ADT) is a treatment option for advanced prostate cancer, please see section androgen deprivation therapy for details.

Antibiotics

Anticholinergics

Chemotherapy of Urologic Tumors

Chemotherapy Regimens in Urology

Targeted Tumor Therapy

Targeted tumor therapy uses drugs against specific metabolic processes in tumor tissue that are of minimal importance in healthy cells. Monoclonal antibodies (suffix "mab") or low-molecular compounds (suffix "mib" or "nib") are used. Targeted drug-based tumor therapy is better tolerated than conventional chemotherapy and can be prescribed for years.

Cancer Immunotherapy

Tumour cells are recognized by the immune system as altered body cells and are eliminated. However, tumors have developed various strategies to evade the immune system. Several mechanisms can be used to stimulate the body's immune system to attack tumor cells again.

Vaccinations:

Examples of specific immunization in urology include vaccination against HPV for the prophylaxis of cervical and penile carcinoma or experimental immunotherapy of prostate carcinoma with Sipuleucel-T (vaccination with activated autologous dendritic cells).

Immune Checkpoints:

Immune checkpoints are molecular biological "brakes" on the immune system. Tumors can influence immune checkpoints through the expression of proteins and thus evade elimination. Important immune checkpoints in urology are the programmed cell death-1 receptor and its ligand PD-L1 or the cytotoxic T lymphocyte antigen (CTLA)-4 receptor. Checkpoint inhibitors (CPIs) are mainly used to treat advanced bladder cancer and metastatic renal cell carcinoma.

Non-specific Activation:

Examples include intravesical immunotherapy of bladder cancer with BCG or parenteral administration of e.g. interferon-alpha and interleukin-2 for the treatment of metastatic renal cell carcinoma.

Contrast Medium

Local Anesthetics

Phosphodiesterase Inhibitors

Substances with Influence on the Acid-Base Balance

Miscellaneous Drugs






Index: 1–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

  Deutsche Version: Medikamente in der Urologie

-->